Cardiometabolic Risk

In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...

In this episode, Anil Harrison, MD, speaks with Dharminder Singh, MD, about the evaluation of renal tubular acidosis (RTA) and how to evaluate metabolic alkalosis. The first patient case presentation is a...

In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with...

In this video, Michael J. Bloch, MD, discusses the use of combined oral contraceptives, which are the most common forms of birth control used by women in the United States, oral estrogen-free progestin-only...

In this episode, Anil Harrison, MD, speaks with Dharminder Singh, MD, about metabolic alkalosis, a patient with surreptitious vomiting, and a patient with primary hyperaldosteronism.

In this episode, Lisa Jones interviews Jennifer Smith, RD, LD, CDCES, and Susan Weiner, MS, RDN, CDN, CDCES, FADCES, about emerging technological advances shaping the management of patients with diabetes,...

In this episode, Anil Harrison, MD, speaks with Paul Shiu, DO, about 3 patient case presentations with mixed acid-base disorders, including concomitant metabolic acidosis and metabolic alkalosis.

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

In this episode, Anil Harrison, MD, speaks with Paul Shiu, DO, about a patient with metabolic alkalosis, including the criteria, the most common causes, and the phases of metabolic alkalosis.

In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...